- Investing Ideas
- South Korean Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
South Korean Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
ALTEOGEN
Market Cap: ₩16.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩308,500.00
7D
2.7%
1Y
-26.9%
L&C BIOLTD
Market Cap: ₩1.4t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩51,900.00
7D
-7.7%
1Y
62.7%